Siwa Biotech Financing
Siwa Biotech Corp., Corporation just submitted form D for $2.00 million equity financing. This is a new filing. Siwa Biotech was able to fundraise $2.00 million. That is 100.00% of the offering. The total fundraising amount was $2.00 million. The financing form was filed on 2016-11-01. The reason for the financing was: Salaries of Executive Officers.
Siwa Biotech is based in Oklahoma. The filler’s business is Biotechnology. The form was signed by William M Canfield Chairman & CEO. The company was incorporated more than five years ago. The filler’s address is: 755 Research Parkway, Suite 125, Oklahoma City, Ok, Oklahoma, 73104. William M Canfield is the related person in the form and it has address: 755 Research Parkway, Suite 125, Oklahoma City, Ok, Oklahoma, 73104. Link to Siwa Biotech Filing: 000165789416000002.
Analysis of Siwa Biotech Offering
On average, firms in the Biotechnology sector, sell 73.77% of the total offering amount. Siwa Biotech sold 100.00% of the offering. Could this mean that the trust in Siwa Biotech is high? The average offering amount for companies in the Biotechnology industry is $3.08 million. The offering was 35.07% smaller than the average of $3.08 million. Of course this should not be seen as negative. Businesses get financed for a variety of reasons and needs. The minimum investment for this financing is set at $3432. If you know more about the reasons for the financing, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Siwa Biotech Also
The Form D signed by William M Canfield might help Siwa Biotech Corp.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.